According to the PD‐1 expression (MFI) on BM CD3+ T lymphocytes of AML patients, there were two groups: a group with high PD‐1 expression (MFI >3.5%) and the other with normal PD‐1 expression (MFI <3.5%). This evidence concerns the gene PDCD1 and acute myeloid leukemia.